Testing the responsiveness of patients admitted to intensive care units to treatment with anti-platelet drugs (acetylsalicylic acid, clopidogrel, prasugrel, ticagrelor)

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-002226-76

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To examine whether high "on treatment" platelet reactivity (HTPR) in acetylsalicylic-acid treated patients can be overcome by using intravenous ASA or crushed chewable ASA tablets or dose increase; To examine the pharmacodynamic response of prasugrel or ticagrelor in patients with HTPR to clopidogrel;


Critère d'inclusion

  • mixed medical intensive care unit patients

Liens